Andrew Schwartz
Pioneering BCI researcher at University of Pittsburgh who led the development of motor BCIs enabling paralyzed individuals to control robotic arms with high degrees of freedom through brain signals.
Background
Andrew Schwartz is a Distinguished Professor of Neurobiology at the University of Pittsburgh School of Medicine and an adjunct faculty member in the Carnegie Mellon Robotics Institute. He is one of the pioneering researchers in the field of motor brain-computer interfaces, with decades of research focused on understanding how motor cortex activity can be translated into precise control of external devices. Schwartz has been instrumental in advancing practical BCIs from theoretical possibility to clinical reality.
Key Contributions
Schwartz led research teams that enabled people with severe paralysis to control anthropomorphic robotic arms using implanted electrode arrays. In landmark studies, his team demonstrated that a woman with longstanding quadriplegia could use a brain-computer interface to control a human-like robot arm with seven degrees of freedom, allowing her to move the arm, rotate and bend the wrist, and close the hand. This work represented a major advance in BCI technology, showing that it was possible to extract sufficiently precise movement commands from motor cortex to control complex, multi-joint robotic limbs. Additionally, Schwartz’s research has extended BCIs beyond motor control to sensory feedback, collaborating with colleagues to demonstrate that patients can experience tactile sensation through robotic arms they control with their brain, creating closed-loop sensory-motor systems.
Current Work
Schwartz continues to advance BCI technology at the University of Pittsburgh, focusing on making BCIs more practical and accessible for real-world use. His current priorities include developing wireless BCIs to eliminate cabled systems, creating robotic arms that can be mounted on wheelchairs for practical daily use, and miniaturizing the computing systems required for BCIs. His vision is to transform BCIs from laboratory demonstrations into genuinely practical assistive devices that restore independence and quality of life for people with severe paralysis.